Health Care · Pharmaceutical Preparations · OTC · CIK 1859007 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.11Day −9.48%Mkt cap $939,1271Y −47.5%Off 52W high −65.0%Vol (1Y) 132.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 908 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.7% of sh out |
| Days to cover1.9d |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Earnings (TTM)-$24.5M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−21.6% |
| 1Y−47.5% |
| 3Y−99.8% |
| Since incept. (ann.)−93.8% |
Total return through 2026-07-30 · series begins 2022-12-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)132.5% |
| Ann. volatility (3Y)159.8% |
| Sharpe (1Y)−0.04 |
| Sharpe (3Y)−0.60 |
| Max drawdown (1Y)−61.1% |
| Max drawdown (3Y)−99.8% |
| Beta (3Y vs SPY)1.39 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for ZVSA.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.22 | — | — | — |
| 2025-09-30 | 2025-11-19 | −$2.56 | — | — | — |
| 2025-06-30 | 2025-08-13 | −$0.46 | — | — | — |
| 2025-03-31 | 2025-05-12 | −$0.73 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 93d) — not company-confirmed.
